Cognition Therapeutics, Inc.
CGTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,971 | -$25,788 | -$21,397 | -$11,716 |
| Dep. & Amort. | $266 | $252 | $235 | $93 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,748 | $4,354 | $3,572 | $5,183 |
| Change in WC | $1,288 | $4,846 | -$943 | $2,842 |
| Other Non-Cash | $195 | $318 | $0 | -$33 |
| Operating Cash Flow | -$28,474 | -$16,018 | -$18,533 | -$3,631 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$147 | -$171 | -$27 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$4 | -$147 | -$171 | -$27 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$739 | -$811 | -$1,396 | -$268 |
| Stock Issued | $24,350 | $5,332 | $5,324 | $44,217 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$46 | $0 | $1,618 | $9,252 |
| Financing Cash Flow | $23,565 | $4,521 | $5,546 | $53,201 |
| Forex Effect | $0 | $4 | -$1 | -$11 |
| Net Chg. in Cash | -$4,913 | -$11,640 | -$13,159 | $49,532 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,922 | $41,562 | $54,721 | $5,189 |
| End Cash | $25,009 | $29,922 | $41,562 | $54,721 |
| Free Cash Flow | -$28,478 | -$16,165 | -$18,704 | -$3,658 |